Protective effect of adenosine and nicotinamide against audiogenic seizure.
D000161:Acoustic Stimulation; D000241:Adenosine / Q000627:therapeutic use*; D000255:Adenosine Triphosphate / Q000096:biosynthesis / Q000097:blood; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001923:Brain Chemistry; D002110:Caffeine / Q000037:antagonists & inhibitors; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D004827:Epilepsy / Q000517:prevention & control*; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009243:NAD / Q000096:biosynthesis / Q000097:blood; D009536:Niacinamide / Q000627:therapeutic use*; D009638:Norepinephrine / Q000378:metabolism; D010725:Phosphocreatine / Q000096:biosynthesis / Q000097:blood; D010761:Phosphorus Radioisotopes; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000097:blood
D006993:Hypnotics and Sedatives; D010761:Phosphorus Radioisotopes; D010725:Phosphocreatine; D009243:NAD; D009536:Niacinamide; D002110:Caffeine; D005680:gamma-Aminobutyric Acid; D000255:Adenosine Triphosphate; D000241:Adenosine; D009638:Norepinephrine